372 related articles for article (PubMed ID: 26792955)
21. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model.
Chang MR; Lyda B; Kamenecka TM; Griffin PR
Arthritis Rheumatol; 2014 Mar; 66(3):579-88. PubMed ID: 24574218
[TBL] [Abstract][Full Text] [Related]
23. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
[TBL] [Abstract][Full Text] [Related]
24. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
Solt LA; Kumar N; Nuhant P; Wang Y; Lauer JL; Liu J; Istrate MA; Kamenecka TM; Roush WR; Vidović D; Schürer SC; Xu J; Wagoner G; Drew PD; Griffin PR; Burris TP
Nature; 2011 Apr; 472(7344):491-4. PubMed ID: 21499262
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.
Huh JR; Littman DR
Eur J Immunol; 2012 Sep; 42(9):2232-7. PubMed ID: 22949321
[TBL] [Abstract][Full Text] [Related]
26. Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity.
Pastwińska J; Karaś K; Sałkowska A; Karwaciak I; Chałaśkiewicz K; Wojtczak BA; Bachorz RA; Ratajewski M
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163824
[TBL] [Abstract][Full Text] [Related]
27. [Generation of engineering Th17 cells and its function evaluation].
Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
[TBL] [Abstract][Full Text] [Related]
29. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
[TBL] [Abstract][Full Text] [Related]
30. Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17.
Takaishi M; Ishizaki M; Suzuki K; Isobe T; Shimozato T; Sano S
J Dermatol Sci; 2017 Jan; 85(1):12-19. PubMed ID: 27726924
[TBL] [Abstract][Full Text] [Related]
31. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
[TBL] [Abstract][Full Text] [Related]
32. Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.
Gao W; Wu Y; Tian Y; Ni B
Int Rev Immunol; 2015; 34(4):295-304. PubMed ID: 25340306
[TBL] [Abstract][Full Text] [Related]
33. CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.
Song P; Chou YK; Zhang X; Meza-Romero R; Yomogida K; Benedek G; Chu CQ
Biochem Biophys Res Commun; 2014 Oct; 452(4):1040-5. PubMed ID: 25241192
[TBL] [Abstract][Full Text] [Related]
34. The Inhibitory Effects of Pentacyclic Triterpenes from Loquat Leaf against Th17 Differentiation.
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
Immunol Invest; 2020 Aug; 49(6):632-647. PubMed ID: 31795780
[TBL] [Abstract][Full Text] [Related]
35. Abnormal CD161
Singh MV; Cicha MZ; Kumar S; Meyerholz DK; Irani K; Chapleau MW; Abboud FM
J Allergy Clin Immunol; 2017 Sep; 140(3):809-821.e3. PubMed ID: 28093217
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003.
Sasaki Y; Odan M; Yamamoto S; Kida S; Ueyama A; Shimizu M; Haruna T; Watanabe A; Okuno T
Bioorg Med Chem Lett; 2018 Dec; 28(22):3549-3553. PubMed ID: 30301676
[TBL] [Abstract][Full Text] [Related]
37. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt.
Lao C; Zhou X; Chen H; Wei F; Huang Z; Bai C
Bioorg Chem; 2019 Sep; 90():103077. PubMed ID: 31323598
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
[TBL] [Abstract][Full Text] [Related]
39. RORs in autoimmune disease.
Chang MR; Rosen H; Griffin PR
Curr Top Microbiol Immunol; 2014; 378():171-82. PubMed ID: 24728598
[TBL] [Abstract][Full Text] [Related]
40. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
